.jpg)
.jpg)
01 Apr, 2020
J&J Shares Fall 6% After Reportedly Knowing Of Asbestos In Baby Powder
Johnson & Johnson (NYSE: JNJ) reportedly knew its talcum baby powder contained asbestos, Reuters said in a report that drove the Company’s shares down by more than 6% on Friday.Reuters reviewed documents from 1971 to the early 2000’s..
Johnson & Johnson Beats on First-Quarter Earnings
On Tuesday, Johnson & Johnson (NYSE: JNJ) announced its financial results for the first quarter of 2018. Boosted by strong pharmaceutical growth, both revenue and earnings of the company beat estimates.According to the company, revenue for the f..
.jpg)
Johnson & Johnson Posted Q4 Results
On Tuesday, Johnson & Johnson (NYSE: JNJ) announced its financial results for the fourth quarter of 2017, with both earnings and revenue beating analysts’ estimates.According to the company, for the fourth quarter, the company posted a net..
Johnson & Johnson's Q3 Earnings Drop but Beat Estimates
On Tuesday, Johnson & Johnson (NYSE: JNJ) announced its financial results for the third quarter of 2017. The company also adjusted its guidance for full-year 2017 in the statement on Tuesday.For the third quarter of 2017, the company announced s..
National Institute of Health partners with 11 Biopharma companies for Cancer Research
The National Institutes of Health and 11 biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT). This is a five-year-public-private research collaboration totaling $215 million as part of the Cancer Moons..
@Newsletter
Sign Up for Weekly UpdatesOpt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!
No articles found.
.jpg){kind=small}
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).